Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Ironwood Pharmaceuticals buy Zacks Research

Start price
€3.86
03.01.26 / 50%
Target price
-
03.01.27
Performance (%)
-11.40%
Price
€3.48
08.01.26
Summary
This prediction is currently active. The price of Ironwood Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.40%. This prediction currently runs until 03.01.27. The prediction end date can be changed by Zacks_Research at any time. Zacks_Research has 50% into this prediction
Performance without dividends (%)
Name 1w
Ironwood Pharmaceuticals -11.40%
iShares Core DAX® 2.659%
iShares Nasdaq 100 0.916%
iShares Nikkei 225® 2.426%
iShares S&P 500 1.230%

Comments by Zacks_Research for this prediction

In the thread Ironwood Pharmaceuticals diskutieren

Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ratings data for IRWD provided by MarketBeat